OR WAIT null SECS
February 02, 2018
Mark Egerton, PhD, chief executive officer of Quotient Sciences, shares insights on a new approach to accelerate drug development, which integrates formulation development, real-time adaptive GMP manufacturing, and clinical research within a single platform.
February 01, 2018
Avista Pharma's strengthens early phase drug development offerings with acquisition of Solid Form Solutions.
Successful outsourcing relationships in early phase drug-development analytics are driven by partnership.
CRLs put the brakes on drug development and damage corporate reputation and stock prices. Upfront investment and better sponsor oversight are ways to prevent them.
Research suggests that working with a single contract partner can reduce development time and improve economics.
Joe DiMasi, director of economic analysis and research associate professor, Tufts Center for the Study of Drug Development (CSDD), discussed research into the impacts of working with single source contractors with Pharmaceutical Technology.
January 26, 2018
The companies will be integrated to form the newly-branded AGC Biologics, which will specialize in customized contract development and manufacturing organization services for the scale-up and cGMP manufacture of protein-based therapeutics.
January 24, 2018
Flexibility, innovation, and creativity are critical for success in navigating the challenges facing the bio/pharmaceutical industry.
KBI Biopharma's acquisition of Elion Labs expands KBI's biophysical and analytical characterization capabilities.
January 16, 2018
The acquisition strengthens Charles River Laboratories’ capabilities in the oncology and immunology therapeutic areas.